<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a patient with hereditary <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> who was successfully treated with <z:chebi fb="5" ids="28304">heparin</z:chebi> throughout pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>Functional antithrombin III levels fell to 0.32 U/ml during <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment, but it was possible to achieve a <z:chebi fb="5" ids="28304">heparin</z:chebi> effect, measured by the activated partial thromboplastin time, thrombin clotting time and <z:chebi fb="5" ids="28304">heparin</z:chebi> assay with subcutaneous <z:chebi fb="5" ids="28304">heparin</z:chebi> in doses of 30,000 U to 35,000 U/24 hours </plain></SENT>
<SENT sid="2" pm="."><plain>This achieve an long term <z:chebi fb="5" ids="28304">heparin</z:chebi> effect was obtained without the need for antithrombin III infusions </plain></SENT>
</text></document>